Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01871714 · ClinicalTrials.gov registry record
Phenotypic Properties in Individuals Affected With XLHED
A clinical trial, sponsored by Edimer Pharmaceuticals.
- Completed
- Registry status
- 30
- Enrollment target
NCT01871714 is a clinical trial that has completed, run by Edimer Pharmaceuticals. The registered enrollment target is 30 participants.
The verdict
NCT01871714 has completed, sponsored by Edimer Pharmaceuticals.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
The current study design incorporates two previously developed, non-invasive approaches to characterize the phenotype of individuals affected with XLHED.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2013-05 |
| Est. Completion | 2013-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01871714
The ClinicalTrials.gov registry entry for NCT01871714 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Edimer Pharmaceuticals, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01871714 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01871714 about?
NCT01871714 is a clinical study titled "Phenotypic Properties in Individuals Affected With XLHED". The current study design incorporates two previously developed, non-invasive approaches to characterize the phenotype of individuals affected with XLHED.
What is the current status of trial NCT01871714?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2013-05. Estimated completion is 2013-09.
Who is sponsoring clinical trial NCT01871714?
This trial is sponsored by Edimer Pharmaceuticals, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.